EcoLiver’s blood-based test is enabled by a novel platform based on organ-specific Extracellular Vesicles (EVs) for the ...

Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

The Concerto™ System introduces a first-of-its-kind multiplexed, multi-omic digital detection platform, enabling real-time, high-plex quantification of DNA, RNA and protein biomarkers from a single ...

Chris Malachowsky is one of Nvidia's three co-founders, and the chief architect of the GPU, or graphics processing unit, who ...

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

Welcome to the Nautilus first quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's pressentation, there will be a question and answer ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...

Pierre Arsène, Founder and CEO of Mursla Bio, said: “This designation is ... of tissue biopsies with the ease of liquid biopsy sample collection, providing a non-invasive intervention with ...

It is fascinating to witness Donald Trump’s ability to project onto his opponents pretty much what he himself is doing or ...